What is the current market size?

The IVD Kits and Testing Services market size was valued at USD 58.2 billion in 2023, driven by rising chronic disease prevalence and advancements in diagnostic technologies.

What is the expected growth rate?

The market is projected to grow at a CAGR of 7.8% from 2024 to 2032, with robust expansion anticipated in emerging economies and decentralized testing sectors.

What are the key drivers of market growth?

Key drivers include increasing R&D investments, demand for rapid diagnostics, and the rise of point-of-care testing solutions in healthcare systems.

What challenges does the market face?

Challenges include stringent regulatory compliance, high development costs, and limited reimbursement policies in low-income regions.

Which regions are leading the market?

North America dominates with 38% market share in 2023, followed by Europe and Asia-Pacific, driven by advanced healthcare infrastructure and government initiatives.

Who are the top companies in the market?

Leading players include Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific, focusing on innovation and strategic partnerships to strengthen market position.

What future opportunities exist?

Opportunities lie in AI-driven diagnostics, home testing kits, and expanding applications in personalized medicine and infectious disease monitoring.

How is technology shaping the market?

Advances in next-generation sequencing, digital pathology, and cloud-based data analytics are enhancing diagnostic accuracy and efficiency, fueling market growth.

What is the regulatory landscape like?

Regulatory frameworks by FDA, EMA, and WHO ensure product safety and quality. Compliance costs are rising due to evolving standards, especially in emerging markets.

IVD Kits and Testing Services Market Outlook, Trends & Forecast 2033

IVD Kits and Testing Services by Application (Online Sales, Offline Sales), by Types (Blood Type and Tissue Matching Reagents, Microbial Antigen, Antibody and Nucleic Acid Detection Reagents, Tumor Marker Reagents, Immunohistochemistry and Human Tissue Cell Reagents, Human Genetic Testing Reagents, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12.7 billion

CAGR: 4.4%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $12.7 billion

CAGR: 4.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

IVD Kits and Testing Services Market Overview

The In Vitro Diagnostic (IVD) Kits and Testing Services market encompasses products and services used for disease detection, monitoring, and health management outside the human body. As a critical enabler of precision medicine and rapid diagnostics, the market is pivotal for healthcare providers, researchers, and pharmaceutical firms. The global IVD Kits and Testing Services market size reached approximately USD 81.5 billion in 2025, driven by rising chronic diseases, advancements in molecular diagnostics, and post-pandemic demand for infectious disease testing. The growth outlook remains robust, with a projected CAGR of 6.8% during 2026–2033, reflecting industry expansion fueled by AI integration, regulatory standardization, and decentralized testing models.

Loading chart…

Key forces shaping the IVD Kits and Testing Services sector include technological shifts toward point-of-care testing (POCT) and AI-driven diagnostics, which enhance accuracy and reduce turnaround times. Regulatory frameworks, particularly in Asia-Pacific and Europe, are streamlining approvals for next-gen diagnostics while ensuring safety standards. Consumer behavior is also evolving, with rising demand for home-based testing kits and personalized health monitoring. North America remains the largest market due to high R&D investments and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, driven by expanding diagnostic labs and government initiatives to improve healthcare access.

Report Overview

Report Attribute	Details
Market size value in 2025	12.70 billion
Revenue forecast in 2033	22.15 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shuwen Biotech; 23andMe; LabCorp; Empower DX; Mega Genomics; Blueprint Genetics; Generi-Biotech; RxHomeTest; Kashi Labs; SolGent; CapitalBio; Genex Diagnostics; Sansure; Agena Bioscience
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The IVD Kits and Testing Services market is witnessing accelerated expansion due to rising prevalence of chronic diseases and infectious outbreaks, driving demand for rapid, accurate diagnostics. Technological advancements in molecular testing and AI-driven analytics are enhancing test specificity, further propelling adoption in clinical and point-of-care settings.

Government initiatives to expand healthcare infrastructure in emerging economies are amplifying the IVD Kits and Testing Services market size. Strategic collaborations between diagnostics firms and public health agencies are also fostering innovation and reducing costs through economies of scale.

Restraints2 items

Stringent regulatory frameworks for IVD product approval, particularly in regions like Europe and North America, are delaying market entry and increasing compliance costs. Delays in regulatory harmonization further fragment market access across geographies.

High R&D expenditures and the need for continuous validation of new testing protocols hinder smaller players from competing effectively, consolidating market power among established firms and slowing overall market agility.

Opportunities2 items

The shift toward personalized medicine is creating untapped demand for specialized IVD kits tailored to genetic and biomarker profiling, unlocking new revenue streams in oncology and rare disease diagnostics.

Digital health integration, including cloud-based diagnostic platforms and telemedicine-enabled testing services, is opening opportunities for remote patient monitoring and decentralized testing workflows.

Challenges2 items

Supply chain vulnerabilities, exacerbated by geopolitical tensions and material shortages, are disrupting production schedules and driving up costs for critical reagents and components.

Price erosion in public healthcare systems, coupled with reimbursement constraints in private markets, is pressuring profit margins and limiting investment in high-accuracy testing solutions.

The IVD Kits and Testing Services market growth forecast remains robust through 2030, underpinned by technological innovation and demographic shifts. However, stakeholders must navigate regulatory complexity and supply chain fragility to sustain competitive advantage.

Market Segmentation

Loading chart…

IVD Kits are segmented by application into hospital diagnostics, point-of-care testing (POCT), and home testing. Hospital diagnostics dominates the IVD Kits and Testing Services segmentation, driven by high-volume testing in inpatient settings and the demand for rapid results in critical care. POCT gains traction in emergency departments and decentralized healthcare environments, leveraging portable analyzers for real-time decision-making. Home testing, while smaller in volume, is growing due to chronic disease management and consumer health trends. By type, IVD Kits are categorized into enzymatic, immunoassay, molecular, and others. Enzymatic kits dominate clinical chemistry applications, while molecular kits benefit from advancements in PCR and nucleic acid detection. Immunoassay kits, used for hormone and infectious disease testing, maintain steady growth, reflecting their versatility across diagnostic workflows.

Testing Services are segmented by application into laboratory-based testing, POCT services, and clinical research support. Laboratory-based testing constitutes the largest share, underpinned by centralized labs handling complex assays and regulatory compliance. POCT services expand in ambulatory care and retail health clinics, driven by streamlined workflows and regulatory approvals. Clinical research support, a niche but high-growth segment, caters to pharmaceutical and biotech sectors for trial-related diagnostics. By type, the market includes diagnostic testing services, screening programs, and specialized testing (e.g., genetic, toxicology). Diagnostic services remain the core, while screening programs for infectious diseases and cancer detection drive scalability. Specialized testing, though fragmented, is influenced by precision medicine and genomic advancements. The market taxonomy for IVD Kits and Testing Services underscores diversification in end-use scenarios and technological differentiation.

IVD Kits and Testing Services Segmentation Breakdown10 items

Application

Online Sales

Offline Sales

Types

Blood Type and Tissue Matching Reagents

Microbial Antigen, Antibody and Nucleic Acid Detection Reagents

Tumor Marker Reagents

Immunohistochemistry and Human Tissue Cell Reagents

Human Genetic Testing Reagents

Others

Regional Insights

Loading chart…

The IVD Kits and Testing Services market growth is dominated by North America, which holds a 40% share globally, driven by advanced healthcare infrastructure, high adoption of next-generation diagnostics, and robust R&D investments. Strategic partnerships between industry players and government agencies further accelerate innovation. Meanwhile, Asia Pacific emerges as the fastest-growing region, fueled by rising chronic disease prevalence, expanding healthcare access, and increasing private-sector investments in diagnostic ecosystems.

In Europe, stringent regulatory frameworks and a focus on precision medicine under EU policies are key growth catalysts, with the region contributing 25% to the market. Adoption of AI-integrated diagnostics and cross-border collaborations among EU nations also enhance ecosystem maturity. Latin America (10% share) is progressing steadily due to public-private partnerships addressing diagnostic gaps, while Middle East & Africa (5% share) leverages digitization and telehealth expansion to overcome infrastructure challenges.

A regional forecast reveals Asia Pacific’s 12% CAGR, outpacing other regions, supported by demographic shifts and rising healthcare expenditure. North America’s market leadership is sustained by mature supply chains and a high penetration rate of automated testing solutions. Conversely, MEA’s growth hinges on policy-driven initiatives to improve disease surveillance and diagnostics in underserved populations.

Competitive Landscape

The IVD Kits and Testing Services market is moderately consolidated, with a blend of global incumbents and regional niche players. Key competitive levers include pricing flexibility, regulatory approvals for new markets, and differentiated product portfolios. Global firms leverage extensive distribution networks and multi-country certifications, while local players focus on tailored solutions and cost-competitive offerings. The IVD Kits and Testing Services competitive landscape is shaped by rapid technological adoption, particularly in molecular diagnostics, and strategic alignment with OEM partners for supply chain resilience.

Competitive differentiation centers on technology (e.g., next-gen sequencing, rapid antigen tests) and service models, such as at-home testing kits or integrated digital health platforms. Common strategies include cross-border partnerships for R&D, vertical integration to mitigate supply chain risks, and localized manufacturing to reduce lead times. A persistent challenge is margin pressure from commoditization of routine tests, which forces players to balance investment in innovation with cost optimization.

Shuwen Biotech: Regional expansion via OEM tie-ups for diagnostic reagents

23andMe: Consumer-focused innovation pipeline in direct-to-consumer genomics

LabCorp: Channel strength through integrated diagnostic network and hospital partnerships

Empower DX: Cost advantages via scalable, automated manufacturing processes

Sansure: Premium pricing for high-sensitivity molecular diagnostic assays

Generi-Biotech: Local manufacturing to bypass customs delays in emerging markets

Key IVD Kits and Testing Services Companies14 items

Shuwen Biotech

23andMe

LabCorp

Empower DX

Mega Genomics

Blueprint Genetics

Generi-Biotech

RxHomeTest

Kashi Labs

SolGent

CapitalBio

Genex Diagnostics

Sansure

Agena Bioscience

Market Ecosystem

The IVD Kits and Testing Services ecosystem spans upstream technology development, midstream manufacturing and integration, and downstream deployment across healthcare settings. Value is generated through innovation in diagnostic platforms, precision in kit production, and accessibility via specialized distribution networks. The ecosystem balances upstream input quality with downstream demand responsiveness.

Raw material/component suppliers — Provide reagents, enzymes, and substrates critical for IVD kit formulation

OEMs/Manufacturers — Design and produce diagnostic kits, testing devices, and associated software

Technology providers — Develop core assay platforms, automation systems, and digital analytics tools

System integrators — Configure end-to-end solutions for lab automation and workflow optimization

Distributors/Channel partners — Facilitate regional sales, logistics, and post-purchase technical support

Regulators/Standards bodies — Govern compliance, safety certifications, and test validation protocols

End users — Hospitals, reference labs, and point-of-care facilities implementing diagnostic testing

Control points reside with regulators, who shape market entry through approval timelines, and OEMs, whose proprietary technologies create switching barriers. Dependency risks emerge from raw material scarcity and interoperability challenges in multi-vendor environments. Regional disparities in regulatory frameworks and healthcare infrastructure further fragment value chain efficiency.

Recent Industry Insights

The IVD Kits and Testing Services industry trends have seen significant momentum over the past 18 months, driven by innovation in diagnostics and strategic collaborations. Key players have prioritized partnerships to enhance capabilities, such as Roche’s collaboration with a leading biotech firm to integrate AI-driven analytics into IVD platforms. Mergers & acquisitions have also accelerated, with Thermo Fisher Scientific acquiring a niche molecular diagnostics company to bolster its genomic testing portfolio. Product launches highlight advancements in rapid testing, including Abbott’s FDA-cleared antigen test with digital connectivity for real-time data tracking. Regulatory shifts, such as the FDA’s updated guidelines for decentralized clinical trials, have spurred growth in home-based testing solutions, aligning with consumer demand for convenience. The enterprise sector has increasingly adopted cloud-based testing services for workplace health monitoring, while startups like Freenome secured $300M in Series C funding to advance non-invasive cancer detection technologies. As the market evolves, AI integration and decentralized testing will likely define the next phase of growth.

Analyst Overview

The IVD Kits and Testing Services market outlook remains robust, driven by rising demand for precision diagnostics, chronic disease prevalence, and advancements in molecular and point-of-care testing. Market attractiveness is underscored by high-growth segments such as infectious disease testing and next-generation sequencing, with emerging economies offering untapped potential.

Competitive intensity is moderate, with a mix of global leaders and regional players. Strategic partnerships, R&D investments, and regulatory adaptability define differentiation. Consolidation is expected as smaller firms seek scale to compete with established innovators like Roche, Abbott, and Thermo Fisher Scientific.

The long-term outlook is optimistic, with a projected CAGR of 6–8% through 2030, fueled by digitalization, AI-driven analytics, and decentralized testing models. Innovation in CRISPR-based diagnostics and AI-integrated platforms is accelerating, though adoption depends on cost-effectiveness and regulatory alignment.

Key Risk Factors3 items

Supply chain vulnerabilities for critical reagents and equipment

Reimbursement challenges in mature markets

Regulatory divergence across geographies

Demand–supply balance is tightening in select segments due to surging point-of-care testing needs, though capacity expansions and automation are mitigating shortages. Strategic foresight will be critical to navigate these dynamics and capitalize on the IVD Kits and Testing Services market outlook.

11 items

1. Executive Summary

2. IVD Kits and Testing Services Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global IVD Kits and Testing Services Market Outlook & Forecast (2021-2033) Value (USD Billion)

6.1. Global IVD Kits and Testing Services Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.1.1. Online Sales

6.1.2. Offline Sales

6.2. Global IVD Kits and Testing Services Market Revenue (USD Billion) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Type and Tissue Matching Reagents

6.2.2. Microbial Antigen, Antibody and Nucleic Acid Detection Reagents

6.2.3. Tumor Marker Reagents

6.2.4. Immunohistochemistry and Human Tissue Cell Reagents

6.2.5. Human Genetic Testing Reagents

6.2.6. Others

6.3. Global IVD Kits and Testing Services Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

7. Global IVD Kits and Testing Services Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global IVD Kits and Testing Services Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Application

7.2.3. North America Value (USD Billion) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Application

7.3.3. South America Value (USD Billion) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Application

7.4.3. Europe Value (USD Billion) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Types

8. Global IVD Kits and Testing Services Market Competition by Key Manufacturers

8.1. Global IVD Kits and Testing Services Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global IVD Kits and Testing Services: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Shuwen Biotech

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. 23andMe

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. LabCorp

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Empower DX

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mega Genomics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Blueprint Genetics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Generi-Biotech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. RxHomeTest

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Kashi Labs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. SolGent

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. CapitalBio

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Genex Diagnostics

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Sansure

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Agena Bioscience

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global IVD Kits and Testing Services Market

Figure 4: Global IVD Kits and Testing Services Market: Drivers

Figure 5: Global IVD Kits and Testing Services Market: Challenges

Figure 6: Global IVD Kits and Testing Services Market: Trends

Figure 7: Global IVD Kits and Testing Services Market: Opportunity

Figure 8: Global IVD Kits and Testing Services Market: Restraint

Figure 9: Global IVD Kits and Testing Services Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global IVD Kits and Testing Services Market Value (USD Billion) By Region

Figure 15: Global IVD Kits and Testing Services Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Billion) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Billion) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global IVD Kits and Testing Services Market Value (USD Billion) By Region

Figure 23: Global IVD Kits and Testing Services Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global IVD Kits and Testing Services Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 3: Global IVD Kits and Testing Services Revenue (USD Billion) And Cagr (%) By Types (2020-2032)

Table 4: Global IVD Kits and Testing Services Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Billion) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Billion) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global IVD Kits and Testing Services Market Value (USD Billion) By Region

Table 10: Global IVD Kits and Testing Services Market Share (%) By Region

Table 11: North America Market Value (USD Billion) (2020-2024) By Country

Table 12: North America Market Value (USD Billion) (2020-2024) By Application

Table 13: North America Market Value (USD Billion) (2020-2024) By Types

Table 14: Europe Market Value (USD Billion) (2020-2024) By Country

Table 15: Europe Market Value (USD Billion) (2020-2024) By Application

Table 16: Europe Market Value (USD Billion) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Billion) (2020-2024) By Types

Table 20: South America Market Value (USD Billion) (2020-2024) By Country

Table 21: South America Market Value (USD Billion) (2020-2024) By Application

Table 22: South America Market Value (USD Billion) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Billion) (2020-2024) By Types

Table 26: Global IVD Kits and Testing Services Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global IVD Kits and Testing Services Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global IVD Kits and Testing Services Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Shuwen Biotech Basic Information And Sales Area

Table 31: Shuwen Biotech. Products Portfolio

Table 32: 23andMe Basic Information And Sales Area

Table 33: 23andMe. Products Portfolio

Table 34: LabCorp Basic Information And Sales Area

Table 35: LabCorp. Products Portfolio

Table 36: Empower DX Basic Information And Sales Area

Table 37: Empower DX. Products Portfolio

Table 38: Mega Genomics Basic Information And Sales Area

Table 39: Mega Genomics. Products Portfolio

Table 40: Blueprint Genetics Basic Information And Sales Area

Table 41: Blueprint Genetics. Products Portfolio

Table 42: Generi-Biotech Basic Information And Sales Area

Table 43: Generi-Biotech. Products Portfolio

Table 44: RxHomeTest Basic Information And Sales Area

Table 45: RxHomeTest. Products Portfolio

Table 46: Kashi Labs Basic Information And Sales Area

Table 47: Kashi Labs. Products Portfolio

Table 48: SolGent Basic Information And Sales Area

Table 49: SolGent. Products Portfolio

Table 50: CapitalBio Basic Information And Sales Area

Table 51: CapitalBio. Products Portfolio

Table 52: Genex Diagnostics Basic Information And Sales Area

Table 53: Genex Diagnostics. Products Portfolio

Table 54: Sansure Basic Information And Sales Area

Table 55: Sansure. Products Portfolio

Table 56: Agena Bioscience Basic Information And Sales Area

Table 57: Agena Bioscience. Products Portfolio

Table 58: Global Market Value (USD Billion) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Billion) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global IVD Kits and Testing Services Market Value (USD Billion) By Region

Table 63: Global IVD Kits and Testing Services Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Billion) (2025-2032) By Country

Table 65: North America Market Value (USD Billion) (2025-2032) By Application

Table 66: North America Market Value (USD Billion) (2025-2032) By Types

Table 67: Europe Market Value (USD Billion) (2025-2032) By Country

Table 68: Europe Market Value (USD Billion) (2025-2032) By Application

Table 69: Europe Market Value (USD Billion) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Billion) (2025-2032) By Types

Table 73: South America Market Value (USD Billion) (2025-2032) By Country

Table 74: South America Market Value (USD Billion) (2025-2032) By Application

Table 75: South America Market Value (USD Billion) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Billion) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

IVD Kits and Testing Services Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.70 billion
Revenue forecast in 2033	22.15 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shuwen Biotech; 23andMe; LabCorp; Empower DX; Mega Genomics; Blueprint Genetics; Generi-Biotech; RxHomeTest; Kashi Labs; SolGent; CapitalBio; Genex Diagnostics; Sansure; Agena Bioscience
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Supply chain vulnerabilities, exacerbated by geopolitical tensions and material shortages, are disrupting production schedules and driving up costs for critical reagents and components.

Price erosion in public healthcare systems, coupled with reimbursement constraints in private markets, is pressuring profit margins and limiting investment in high-accuracy testing solutions.

Market Segmentation

Loading chart…

IVD Kits and Testing Services Segmentation Breakdown10 items

Application

Online Sales

Offline Sales

Types

Blood Type and Tissue Matching Reagents

Microbial Antigen, Antibody and Nucleic Acid Detection Reagents

Tumor Marker Reagents

Immunohistochemistry and Human Tissue Cell Reagents

Human Genetic Testing Reagents

Others

Regional Insights

Loading chart…

Competitive Landscape

Shuwen Biotech: Regional expansion via OEM tie-ups for diagnostic reagents

23andMe: Consumer-focused innovation pipeline in direct-to-consumer genomics

LabCorp: Channel strength through integrated diagnostic network and hospital partnerships

Empower DX: Cost advantages via scalable, automated manufacturing processes

Sansure: Premium pricing for high-sensitivity molecular diagnostic assays

Generi-Biotech: Local manufacturing to bypass customs delays in emerging markets

Key IVD Kits and Testing Services Companies14 items

Shuwen Biotech

23andMe

LabCorp

Empower DX

Mega Genomics

Blueprint Genetics

Generi-Biotech

RxHomeTest

Kashi Labs

SolGent

CapitalBio

Genex Diagnostics

Sansure

Agena Bioscience

Market Ecosystem

Raw material/component suppliers — Provide reagents, enzymes, and substrates critical for IVD kit formulation

OEMs/Manufacturers — Design and produce diagnostic kits, testing devices, and associated software

Technology providers — Develop core assay platforms, automation systems, and digital analytics tools

System integrators — Configure end-to-end solutions for lab automation and workflow optimization

Distributors/Channel partners — Facilitate regional sales, logistics, and post-purchase technical support

Regulators/Standards bodies — Govern compliance, safety certifications, and test validation protocols

End users — Hospitals, reference labs, and point-of-care facilities implementing diagnostic testing

Recent Industry Insights

Analyst Overview

Key Risk Factors3 items

Supply chain vulnerabilities for critical reagents and equipment

Reimbursement challenges in mature markets

Regulatory divergence across geographies

Table of Contents